Research  >  Research centres  >  HOPE Research Centre  >  Publications
Share:  
|
PAGE
MENU

Publications

Selected peer-reviewed publications

  1. Rahman F, Seung SJ, Cheng SY, Saherawala H, Earle CC, Mittmann N. Radiation costing methodologies: a systematic review. Curr Oncol. 2016;23(4):e392–e408.
  2. Liu N, Mittmann N, Coyte P, Hancock-Howard R, Seung, SJ, Earle CC. Phase-specific health care costs of cervical cancer: estimates from a population-based study. Am J Obstet and Gynecol. Epub 2015 Nov 25.
  3. Lien K, Tam V, Ko Y, Mittmann N, Cheung M, Chan K. Impact of country-specific EQ-5D tariffs on the economic value of systemic therapies used in the treatment of metastatic pancreatic cancer. Curr Oncol. 2015;22(6):e443–e452.
  4. Raju RS, Coburn N, Liu N, Porter JM, Seung SJ, Cheung MC, Leighl NB, Hoch JS, Trudeau ME, Evans WK, Kainty KN, Earl CC, Mittmann N. A population-based study of the epidemiology of pancreatic cancer: a brief report. Curr Oncol. 2015; 22(6):e478–e484.
  5. Cheung MC, Earle CC, Ho TH, Rangrej J, Liu N, Barbera L, Saskin R, Porter J, Seung SJ, Mittmann N. Impact of aggressive management and palliative care on end-of-life costs. Cancer. 2015 Sep 15;121(18):3307–15.
  6. Nanwa N, Kendzerska T, Krahn MD, Kwong J, Daneman N, Witmann W, Mittmann N, Cadarette S, Rosella L, Sander B. The economic impact of Clostridium difficile: a systematic review. Am J Gastroenterol. 2015;110(4):511–9.
  7. Heelan K, Hassan S, Bannon G, Knowles S, Walsh S, Shear NH, Mittmann N. Loss of work productivity and quality of life in patients with autoimmune bullous dermatoses. J Cutan Med Surg. Epub 2015 Apr 17.
  8. Mittmann N, Porter NJ, Rangrej J, Seung SJ, Liu N, Saskin R, Cheung MC, Leighl NB, Hoch JS, Trudeau M, Evans WK, Dainty KN, DeAngelis C, Earle CC. Health system costs for stage-specific breast cancer: a population based approach. Curr Oncol. 2014;21(6):281–93.
  9. Mittmann N, Seung SJ, Liu N, Porter J, Saskin R, Hoch JS, Evans WK, Leighl NB, Trudeau M, Earle CC. Population based utilization of radiation therapy by a Canadian breast cancer cohort. Curr Oncol. 2014;21(5):e715–7.
  10. Chan BC, Seung SJ, McLean D, Bell H, Bell M, Shear NH, Mittmann N. Etanercept patient assistance program: another data source for epidemiological studies? Adv Pharmacoepidem Drug Safety. 2013;2:132. doi: 10.4172/2167-1052.1000132.

Selected peer-reviewed abstracts

  1. DeAngelis C, Cheung SY, Rahman F, Seung SJ, Earle CC, Chan K, Mittmann N. Characterizing the utilization of the Trillium Drug Program by an oncology patient population. ARCC. 2016 May 8–9; Toronto, Canada.
  2. Mittmann N, Seung SJ, Cheng SY, Rahman F, Earle CC. Determining the cost of equipment and supplies of radiation therapy departments using management information systems data. ARCC. 2016 May 8–9; Toronto, Canada.
  3. Kagedan DJ, Raju R, Dixon M, Shin E, Li Q, Liu N, Elmi M, El-Sedfy A, Earle CC, Mittmann N, Coburn NG. Beyond the dollar: influence of sociodemographic marginalization on survival and adjuvant therapy following resection of pancreatic cancer. IHPBA World Congress. 2016 Apr 20–23; Sao Paulo, Brazil.
  4. Seung SJ, Cheng SY, Rahman F, Earle CC, Mittmann N. Costs of personnel involved with radiation therapy using administrative databases. Canadian Association for Population Therapeutics. 2015 Nov 1–3; Toronto, Canada. J Popul Ther Clin Pharmaco. 2015; 22(3):e272.
  5. Mittmann N, Hassan S, Patel J, Tinmouth J. Cost-effectiveness of directly mailed FOBT kits to previous responders being recalled for screening. Value in Health. 2015 Nov;18(7):A458. doi: 10.1016/j.jval.2015.09.1178.
  6. Mittmann N, Seung SJ, Cheng S, Liu N, Camacho X, Maclagan L, DeAngelis C, Earle CC. Generating costing algorithms for oncology drugs using administrative databases. Applied Research in Cancer Control Conference. 2015 May 24–25; Montreal, Canada.
  7. Naik H, Howell D, Qiu X, Brown C, Vennettilli A, Irwin M, Pat V, Solomon H, Wang T, Hon H, Eng L, Mahle M, Tiessen M, Thai H, Ho V, Pringle D, Xu W, Seung SJ, Mittmann N, Liu G. Canadian cancer site-specific health utility values: Creating the basis for measuring value and costs of therapy. American Society of Clinical Oncology Quality Care Symposium. 2014 Oct 17–18; Boston, U.S.
  8. Mittmann N, Hassan S, Seung SJ, Bannon G, Cheung M, Fraser G, Fine S, Kuriakose B. Health care resource utilization in the management of chronic lymphocytic leukemia at an Ontario cancer centre. Applied Research in Cancer Control Conference. 2014 May 11–12; Toronto, Canada.
  9. Seung SJ, Bannon G, Barbera L, Myers J, Krahn M, Peacock S, Leighl N, Hoch J, Earle C, Mittmann N. Creation of a reference set of the health preference values in oncology: a pilot study using an electronic data collection system. Canadian Association for Population Therapeutics Conference. 2013 Nov 17–19; Toronto, Canada. J Popul Ther Clin Pharmacol. 2014;21(1):e123.
  10. Seung SJ, El-Hadi W, Raymond V, Bannon G, Mittmann N. Cost-effectiveness analysis of apixaban compared to warfarin for stroke prevention in atrial fibrillation (SPAF) in Canada. Canadian Association for Population Therapeutics Conference. 2013 Nov 17–19; Toronto, Canada. J Popul Ther Clin Pharmacol. 2014;21(1):e131.